Objectives Cetuximab plus leucovorin, fluorouracil and oxaliplatin (FOLFOX-4) is superior to FOLFOX-4 alone as a first-line treatment for patients with metastatic colorectal cancer with RAS wild-type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results